Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

DoJ Investigation Of Renal Care Includes Pharma Company Relationships

This article was originally published in The Pink Sheet Daily

Executive Summary

The subpoena is similar to those received by three other top dialysis services providers, Renal Care says.

You may also be interested in...



DaVita, Renal Care Group Under Investigation By U.S. Attorney In Brooklyn

Both dialysis firms have been asked to produce documents related to vitamin D therapies and testing for parathyroid hormone levels. DaVita is requesting a meeting with DoJ to discuss the scope of the subpoena and the production of documents.

Gambro Settles Medicare Billing Suit, Signs Corporate Integrity Agreement

The company will pay up to $355 mil. to settle a Medicare billing fraud civil suit initiated by the Department of Justice. Gambro is absolved of claims against a dialysis supply subsidiary in exchange for a guilty plea to a single felony charge.

Merck Tax Settlement Could Be Smaller Than GSK’s $3.4 Bil. IRS Deal

A possible settlement between Merck and tax authorities could be significantly smaller than GlaxoSmithKline's recent settlement with the IRS based on the companies' projected liability

Topics

UsernamePublicRestriction

Register

PS143249

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel